Virtual workouts tested to boost fitness in metastatic breast cancer

NCT ID NCT05468034

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a 16-week virtual exercise program can improve fitness, muscle strength, and quality of life in people with indolent (slow-growing) metastatic breast cancer. Participants work with a trainer three times a week via video calls. The goal is to see if exercise can help people feel better and stay stronger, even with advanced cancer.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
supervised virtual exercise training (aerobic and resistance)
What this could lead to
If it works, this could show that regular virtual exercise helps people with stable metastatic breast cancer feel better, move better, and maintain muscle.
What could go wrong
This is a small, early-stage study with only 100 participants. Exercise may not improve outcomes for everyone, and results may not apply to those on chemotherapy or with progressive disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • IU Health Joe and Shelly Schwarz Cancer Center

    WITHDRAWN

    Carmel, Indiana, 46032, United States

  • IU Health West

    WITHDRAWN

    Avon, Indiana, 46123, United States

  • Indiana University Melvin & Bren Simon Cancer Center

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Sidney and Lois Eskenazi Hospital

    WITHDRAWN

    Indianapolis, Indiana, 46202, United States

  • Yale Cancer Center

    COMPLETED

    New Haven, Connecticut, 06510, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.